If your levels are only mildly low, supplements may be sufficient
It moves the discussion beyond hype and gives patients a practical distinction they can actually use when thinking about the next step in their weight-loss journey
Sales: $27.1 Billion Headcount: 18,000 Revenues: $27,116 (flat) Net Income: $5,613 (+23%) R&D Expenses: $5,718 (+15%) Gileads full year 2023 revenue decreased 1% to $27.1 billion compared to 2022, largely driven by a reduction of $1.7 billion in Veklury sales, but offset by higher HIV and Oncology sales
In October 2025, Rybelsus also received FDA approval to reduce the risk of major adverse cardiovascular risks in adults with type 2 diabetes
This prevents contamination and keeps the medication sterile
Both compounds serve specific therapeutic purposes that address real concerns patients have during GLP-1 treatment